An Open-label, Long-term Administration Study of S-8117 in Patients with Chronic Pai
Phase 3
- Conditions
- Chronic pain
- Registration Number
- JPRN-jRCT2080222035
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with pain for at least 12 weeks, and the pain is diagnosed as chronic pain such as osteoarthritis, diabetic neuropathy, or postherpetic neuralgia. And etc.
Exclusion Criteria
Patients with previous or present allergy or hypersensitivity to opium alkaloids.
Patients who participated in a clinical trial of S-8117 previously and received S-8117.
And etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insufficient analgesic response rate
- Secondary Outcome Measures
Name Time Method